65 related articles for article (PubMed ID: 21457440)
21. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
[TBL] [Abstract][Full Text] [Related]
22. Atrial fibrillation after typical atrial flutter ablation: a long-term follow-up.
Bandini A; Golia P; Caroli E; Biancoli S; Galvani M
J Cardiovasc Med (Hagerstown); 2011 Feb; 12(2):110-5. PubMed ID: 21045718
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of MAGE in peritoneal washes in gastric carcinoma patients without peritoneal metastasis: results of a 5-year follow-up study.
Jeon CH; Shin IH; Park JB; Chae HD
J Clin Gastroenterol; 2010; 44(10):682-6. PubMed ID: 20421806
[TBL] [Abstract][Full Text] [Related]
24. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation.
Tandon P; Goodman KJ; Ma MM; Wong WW; Mason AL; Meeberg G; Bergsten D; Carbonneau M; Bain VG
Am J Gastroenterol; 2009 Jul; 104(7):1700-6. PubMed ID: 19471253
[TBL] [Abstract][Full Text] [Related]
25. [Survival in patients with liver cirrhosis at the Durango, IMSS Regional General Hospital].
Rodríguez-Hernández H; Jacobo-Karam JS; Castañón-Santillán Mdel C; Arámbula-Chávez M; Martínez-Aguilar G
Gac Med Mex; 2002; 138(4):325-30. PubMed ID: 12200877
[TBL] [Abstract][Full Text] [Related]
26. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
Chu CM; Liaw YF
Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
28. Independent prognostic factors in patients with liver cirrhosis.
Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
[TBL] [Abstract][Full Text] [Related]
29. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.
Manousou P; Dhillon AP; Isgro G; Calvaruso V; Luong TV; Tsochatzis E; Xirouchakis E; Kalambokis G; Cross TJ; Rolando N; O'Beirne J; Patch D; Thornburn D; Burroughs AK
Liver Transpl; 2011 Feb; 17(2):178-88. PubMed ID: 21280191
[TBL] [Abstract][Full Text] [Related]
30. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of renal patients from the Ivory Coast transplanted abroad: time for a local kidney transplantation program.
Ackoundou-N'Guessan C; Gnionsahe DA; Dekou AH; Tia WM; Guei CM; Moudachirou AM
Transplant Proc; 2010 Nov; 42(9):3517-20. PubMed ID: 21094807
[TBL] [Abstract][Full Text] [Related]
32. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
[TBL] [Abstract][Full Text] [Related]
33. The Essen Stroke Risk Score in one-year follow-up acute ischemic stroke patients.
Fitzek S; Leistritz L; Witte OW; Heuschmann PU; Fitzek C
Cerebrovasc Dis; 2011; 31(4):400-7. PubMed ID: 21346341
[TBL] [Abstract][Full Text] [Related]
34. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
Takada Y; Otsuka M; Todoroki T; Fukao K
Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
[TBL] [Abstract][Full Text] [Related]
35. Serum sodium predicts prognosis in critically ill cirrhotic patients.
Jenq CC; Tsai MH; Tian YC; Chang MY; Lin CY; Lien JM; Chen YC; Fang JT; Chen PC; Yang CW
J Clin Gastroenterol; 2010 Mar; 44(3):220-6. PubMed ID: 19636261
[TBL] [Abstract][Full Text] [Related]
36. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid.
Kuiper EM; Hansen BE; Adang RP; van Nieuwkerk CM; Timmer R; Drenth JP; Spoelstra P; Brouwer HT; Kuyvenhoven JP; van Buuren HR;
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1495-502. PubMed ID: 21389798
[TBL] [Abstract][Full Text] [Related]
37. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
[TBL] [Abstract][Full Text] [Related]
38. Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer.
Pinkawa M; Piroth MD; Holy R; Fischedick K; Schaar S; Borchers H; Heidenreich A; Eble MJ
Radiother Oncol; 2010 Jul; 96(1):25-9. PubMed ID: 20231039
[TBL] [Abstract][Full Text] [Related]
39. QT interval analysis in patients with chronic liver disease: a prospective study.
Kosar F; Ates F; Sahin I; Karincaoglu M; Yildirim B
Angiology; 2007; 58(2):218-24. PubMed ID: 17495272
[TBL] [Abstract][Full Text] [Related]
40. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
